Increasing Prevalence of Chronic Diseases and Rising Geriatric Population Propel Middle East & Africa Advanced Medical Stopcock Market Growth
The growing consumption of tobacco and alcohol, poor nutrition, and the lack of physical activity are among the leading causes of chronic diseases such as heart disease, cancer, chronic lung disease, stroke, Alzheimer’s disease, diabetes, and chronic kidney disease. Rapid unplanned urbanization, unhealthy lifestyle adoption, and a rising aging population are a few other factors increasing the risk of chronic diseases.
According to the WHO, the rising geriatric population is increasing the incidence of chronic obstructive pulmonary disease, multiple chronic conditions, hypertension, diabetes, depression, and various other diseases.
Moreover, chronic diseases are mostly preventable and treatable at the initial stage of disease. The severity can be avoided by taking a few preventive measures. Further, diabetes is a life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are among the major complications associated with diabetes.
The treatment for chronic diseases includes medication, intravenous therapies, or surgical procedures. Most chronic diseases are treated with infusion therapy, requiring infusion pumps. An infusion pump is a medical device that delivers fluids, such as nutrients and medications, into a patient body in precise amounts. Medical stopcock is connected to the IV infusion set of an infusion pump. Thus, the growing geriatric population and rising prevalence of chronic diseases drive the growth of the Middle East & Africa advanced medical stopcock market.
Middle East & Africa Advanced Medical Stopcock Market Overview
The Middle East & Africa advanced medical stopcock market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia is expected to account for the largest market share in the coming years and develop moderately in the Middle East & Africa. The market growth is attributed to various factors such as significant development in healthcare facilities, the high adoption rate of IV therapy, and the geographic expansion of market players.
Middle East & Africa Advanced Medical Stopcock Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Advanced Medical Stopcock Market Segmentation
The Middle East & Africa advanced medical stopcock market is segmented based on type, end user, and country. Based on type, the Middle East & Africa advanced medical stopcock market is segmented into low-pressure stopcock, medium-pressure stopcock, and high-pressure stopcock. The low-pressure stopcock segment held the largest market share in 2022.
Based on end user, the Middle East & Africa advanced medical stopcock market is segmented into hospitals & clinics, ambulatory surgical centers, and homecare. The hospitals & clinics segment held the largest market share in 2022.
Based on country, the Middle East & Africa advanced medical stopcock market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa advanced medical stopcock market share in 2022.
B. Braun SE; Smiths Medical Inc; Nipro Corp; Elcam Medical Group Co.; Merit Medical Systems Inc.; Nordson Corp; and Utah Medical Products Inc. are the leading companies operating in the Middle East & Africa advanced medical stopcock market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 94.29 Million |
| Market Size by 2028 | US$ 119.25 Million |
| CAGR (2022 - 2028) | 4.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East & Africa Advanced Medical Stopcock Market is valued at US$ 94.29 Million in 2022, it is projected to reach US$ 119.25 Million by 2028.
As per our report Middle East & Africa Advanced Medical Stopcock Market, the market size is valued at US$ 94.29 Million in 2022, projecting it to reach US$ 119.25 Million by 2028. This translates to a CAGR of approximately 4.0% during the forecast period.
The Middle East & Africa Advanced Medical Stopcock Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Advanced Medical Stopcock Market report:
The Middle East & Africa Advanced Medical Stopcock Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Advanced Medical Stopcock Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Advanced Medical Stopcock Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Advanced Medical Stopcock Market
